| Financial Year |
March 31 2023 |
| Monetary Funds |
408,415,419.26 |
| Held-for-trading Financial Assets |
392,778,582.28 |
| Notes Receivable |
200,000.00 |
| Accounts Receivable |
316,427,473.21 |
| Advances to Suppliers |
5,278,910.71 |
| Other Receivables |
55,924,032.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
113,393,626.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,986,600.54 |
| Total Current Assets |
1,298,417,172.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,980,509.48 |
| Investment Properties |
27,246,142.47 |
| Fixed Assetes |
1,006,345,959.77 |
| Under-construction Projects |
25,330,158.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,173,146.21 |
| R&D expenses |
-- |
| Goodwill |
135,604,327.01 |
| Long-Term Deferred and Prepaid Expenses |
954,054.76 |
| Deferred Income Tax Assets |
18,556,897.58 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,382,930,624.81 |
| Total Assets |
2,681,347,797.24 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
198,525,059.82 |
| Accounts Received In Advance |
9,138,670.20 |
| Employee Compensation Payable |
6,442,125.69 |
| Taxes Payable |
21,565,662.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,821,236.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
212,352.76 |
| Other Current Liabilities |
59,907,464.55 |
| Sub-Total of Current Liabilities |
627,043,149.70 |
| Long-term Loans |
210,065,156.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,101,780.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
262,339,342.80 |
| Total Liabilities |
889,382,492.50 |
| Paid-In Capital(Or Share Stock) |
189,382,714.00 |
| Capital Surplus |
925,239,722.47 |
| Surplus Reserve |
112,374,458.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
395,324,069.34 |
| Minority Stockholder's Interest |
146,178,804.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,645,786,499.82 |
| Owner's Equity（Stockholder's Equity） |
1,791,965,304.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,681,347,797.24 |
